Mother of Three Dies After AstraZeneca COVID Vaccine Causes Blood Brain Diseases + More • Protecting Children’s Health


Defender’s COVID NewsWatch provides a roundup of the latest news headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.

Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

Mother-of-Three, 47, Dies After AstraZeneca COVID Jab Suffers Bleeding To Her Brain Resulting From A Stroke

The Daily Mail reports:

A mother of three has died after suffering a rare catastrophic reaction to AstraZeneca coronavirus jab, his family said.

Lucy Taberer, 47, became seriously ill after taking the jab and developed blood to blood in his brain causing a stroke.

Her grieving fiancé Mark Tomlin, from Aylestone in Leicester, has already spoken of the devastating impact his death had on the family including five -year -old son Orson.

FDA Adds Heart Inflammation Warning to Pfizer, Moderna COVID Vaccines as Experts Call for Full Approval

Defender reports:

The U.S. Food and Drug Administration (FDA) on June 25 adds a warning to patient and provider fact sheets with Pfizer and Modern COVID vaccines indicate an increased risk of myocarditis and pericarditis after vaccination.

the warning notes Reports of adverse events suggest an increased risk of myocarditis and pericarditis, especially following the second dose and onset of symptoms a few days after vaccination.

CDC Reports 4,115 Breakthrough COVID Cases Involving Hospitalizations or Deaths

Fox News said:

the Centers for Disease Control and Prevention (CDC) received reports of 4,115 patients having COVID-19 VACCINE success cases hospitalized or died. Of the cases, 26% of those hospitalized were reported asymptomatic or unrelated to COVID-19, and 19% of the 750 deaths were reported asymptomatic or unrelated to COVID-19.

The data, which is comprehensive as of June 21, is among the 150 million people who have been fully vaccinated in the United States Nearly half of the successful cases, or 49%, involve women, and 3,124, or 76%, occurred in patients age 65 years and older.

San Antonio Teen Participates in Moderna COVID Vaccine Trial for Children Ages 12-17

KENS 5 reports:

A second-choice vaccine for teens may be available if the FDA provides emergency clearance with Modern to manage it COVID-19 vaccine in children aged 12-17.

A San Antonio girl says she joined the trial with the hope that it will help the children live a normal life.

“I was a bit hesitant at first but I knew that trying the vaccine would help make the vaccine come out faster,” Angelina told KENS 5.

COVID Kills 26 Indonesian Doctors in June – At Least 10 Get Sinovac Vaccine in China

The Wall Street Journal reports:

At least 10 of the 26 Indonesian doctors have died from COVID-19 this month received the same dose of vaccine that it did Sinovac Biotech Ltd., a medical association said, raising questions about the Chinese-made being used in many parts of the developing world.

The group that convened the COVID-19 Indonesian Medical Association is still working to verify the vaccination status of 16 more, according to Dr. Adib Khumaidi, who led the group. According to the latest group figures, in a five-month period, at least 20 doctors who had been fully inoculated with Sinovac’s vaccine died from COVID-19, accounting for more than a fifth. generally died by doctors over a period of time.

51.18% of Children in Mumbai Have COVID Antibodies, According to the Zero Survey

NDTV reported:

More than 51 percent of the total pediatric child population – those under 18 – have antibodies with COVID-19, a zero survey conducted by the city between April 1 and June 15 revealed.

2,176 blood samples collected from lab labs across Mumbai showed the highest prevalence of zero (53.43 per cent) for children aged 10 and 14. Children aged 15 -18 shows a 51.39 percent zero spread and between one and four shows a 51.04 percent zero spread.

Saudi Arabia to inoculate 12 to 18-year-olds With Pfizer Vaccine-Ministry

Reuters via US News and World Report reports:

Saudi Arabia will start inoculating young people aged 12 to 18 against COVID-19 with the Pfizer-BioNtech vaccine after it was approved by the Saudi Food and Drug Authority, the health ministry said in a tweet on Sunday.

Experts Consider Whether J&J COVID Vaccine Recipients Should Booster as Delta Variant Hold

The San Diego Times reports:

Infectious disease experts are evaluating the need for shotguns using Pfizer / BioNTech or Moderna mRNA vaccines for Americans who have received a single-dose Johnson & Johnson vaccine.

The diagnosis occurred because of the increased prevalence of the more contagious Delta different coronavirus.

The Response to COVID Vaccines Varies in Blood Cancer Patients

Medical Xpress reported:

Patients with a type of blood cancer called multiple myeloma have a more modified response. COVID-19 vaccines-in some cases, with no noticeable response-highlight the need for antibody testing and precautions for patients after vaccination, according to a study published in Cancer Cell this week .

Researchers at Mount Sinai have found multiple myeloma patients further modification and sometimes suboptimal responses after receiving Pfizer-BioNTech or Moderna COVID-19 vaccines. Nearly 16 percent of these patients go undetected antibodies afterwards Similarly vaccine dose. These findings may be relevant to others cancer patients undergoing treatment and in immunocompromised patients.

London Sees Massive Drops in COVID Vaccine Despite Pressure to Inoculate Young People

The Evening Standard reports:

The number of jabs given in the capital fell alarmingly last week despite efforts to encourage young people in London to get vaccinated.

A total of 374,941 first and second COVID-19 Vaccine doses taken in the last seven days, nearly 52,000 or 12 percent less than the 426,648 given last week, can be revealed by the Standard.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *